Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE

Gooderham, Melinda JMelinda JGooderhamCHIA-YU CHURojo, RicardoRicardoRojoValdez, HernanHernanValdezBiswas, PinakiPinakiBiswasCameron, Michael CMichael CCameronet al.,et al.2022-09-202022-09-202021-0926663287https://scholars.lib.ntu.edu.tw/handle/123456789/621182enabrocitinib; atopic dermatitis; combination therapy; cost; economic impact; monotherapyEconomic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPAREjournal article10.1016/j.jdin.2021.05.004344093912-s2.0-85115996647https://api.elsevier.com/content/abstract/scopus_id/85115996647